Fri, Mar 08, 2013 04:46 – Pharmstar Pharmaceuticals, Inc. (PHAR: OTC Link) released their Attorney Letter with Respect to Current Information concerning Attorney Opinion Letter for PharmStar Pharmaceuticals, Inc. 2012 Annual Report.. To read the complete report, please visit: https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=100721.
Mon, Mar 04, 2013 12:00 – Taisho Pharmaceuticals (TSOPF: Grey Market) – Deleted Symbol – As of Mon, Mar 04, 2013, TSOPF is no longer a valid symbol. You may find a complete list of deleted symbols at otcmarkets.com.
Fri, Jan 18, 2013 12:00 – Aeolus Pharmaceuticals, Inc. (AOLS: OTC Link) – Venue Change – The symbol, AOLS, no longer trades on OTC Link/FINRA BB. As of Fri, Jan 18, 2013, AOLS trades on OTC Link. You may find a complete list of venue changes at otcmarkets.com.
Category : World News
Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting its previous decision to stay the preliminary injunction in the case against Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International Medical Systems. MNTA CEO Craig Wheeler notes the opinion is a setback for the company and has “potentially wide ranging implications for all patent holders.” Shares +3.6% AH. Post your comment!
Read this article: Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting its previous decision to stay the preliminary injunction in the case against Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International…
Little-known Arena Pharmaceuticals just got a big boost from the FDA, which gave its stamp of approval on the company’s weight loss drug, known as Belviq.
See more here: Arena surges on weight loss drug approval
NEW YORK (Real Money) — A couple times a week, I check my sector scans to get a sense of which are home to the largest number of top-performing stocks. For the past several weeks, the number of companies from the health care sector has far outweighed the runner-up consumer sector.
Earlier this week, I wrote about a couple of smaller stocks with charts showing some potential, but the leaders run the gamut when it comes to market cap.
One longtime standout that remains a winner is Alexion Pharmaceuticals, which is up 30% so far this year. Between July and March, the stock notched gains every month. It’s not surprising to see the shares finally in consolidation mode, having pulled back from their March 23 all-time high of $95.01. …
Click to view a price quote on ISRG.Click to research the Health Services industry.
See the original post here: Big-Cap Health Care Winners
A new CEO, Alex Gorsky, is taking over this giant maker of pharmaceuticals and other health products. Job one: Improve Johnson & Johnson’s quality control.
More here: Investing in U.S. health spending? Think J&J